Greytown Advisors Inc. Pfizer Inc Transaction History

Greytown Advisors Inc.

$169 Million
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $20,773 - $26,982	-795 Reduced 10.15%	7,040 $202,000
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $195,845 - $228,923	-6,103 Reduced 43.79%	7,835 $259,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $144 - $167	4 Added 0.03%	13,938 $511,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $52,821 - $68,766	-1,341 Reduced 8.78%	13,934 $568,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $50,350 - $65,727	-1,206 Reduced 7.32%	15,275 $782,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $192,631 - $235,154	-4,402 Reduced 21.08%	16,481 $721,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $273,038 - $323,737	-5,868 Reduced 21.94%	20,883 $1.1 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $304,557 - $377,385	-6,657 Reduced 19.93%	26,751 $1.39 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $152,636 - $226,257	-3,694 Reduced 9.96%	33,408 $1.97 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $103,816 - $133,360	2,645 Added 7.68%	37,102 $1.6 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $308,107 - $349,034	8,580 Added 33.16%	34,457 $1.35 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $195,514 - $220,501	5,838 Added 29.13%	25,877 $938,000
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $183,348 - $233,143	5,478 Added 37.62%	20,039 $738,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $222 - $260	7 Added 0.05%	14,561 $534,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $351,169 - $426,019	-11,659 Reduced 44.48%	14,554 $476,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $67,683 - $96,704	2,504 Added 10.56%	26,213 $856,000
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $8,526 - $9,676	-259 Reduced 1.08%	23,709 $929,000
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $68,099 - $88,304	2,096 Added 9.58%	23,968 $861,000
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $144,554 - $162,301	-3,909 Reduced 15.16%	21,872 $947,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $21,562 - $23,690	-575 Reduced 2.18%	25,781 $1.1 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $18,927 - $21,579	492 Added 1.9%	26,356 $1.15 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $180,174 - $218,540	-5,227 Reduced 16.81%	25,864 $1.14 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $68,895 - $73,449	2,089 Added 7.2%	31,091 $1.13 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $81,817 - $94,919	2,564 Added 9.7%	29,002 $1.03 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $100,711 - $106,858	3,028 Added 12.93%	26,438 $958,000
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $725,710 - $799,451	23,410	23,410 $836,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.

Account